The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

Insulet anticipates that the Omnipod 5 algorithm update will launch in the US in H1 2026. The company highlighted that the ...

Insulet (PODD) announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System.

Insulet could be joining the competition to develop 'artificial pancreas' devices following the release of positive feasibility data for its solution. The Massachusetts-based company's 'hybrid ...

Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.

Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes complete with a wearable continuous glucose monitor (CGM) and insulin pump.

The Omnipod 5 worn in a swimming pool. [Image courtesy of Insulet] Insulet (Nasdaq: PODD) + today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system. At ...

ISKANDAR PUTERI: US-based Insulet Corp (Insulet) plans to expand its Malaysian manufacturing plant in the coming years as part of the company’s US$200mil investment in Johor. According to its ...

From how to French brain or play the guitar to how to unclog a sing or perform CPR, you can learn all kinds of useful skills on YouTube. We at Mental Floss are always eager to learn new things and ...

SAN DIEGO — Forty-three percent of medical residents report using generative AI-based tools daily, but many expressed concerns about overreliance or proper use of AI, according to data presented at ...

Ashley McEvoy. [Image courtesy of Insulet] Insulet (Nasdaq: PODD) + today hosted its Investor Day event, led by President and CEO Ashley McEvoy, laying out the future for the insulin pump maker. Ahead ...